Drug Patents: The Pharma Industry's Hidden Cash Grab?
The debate over drug patents is heating up, with critics accusing Big Pharma of gaming the system. But is this just noise, or a genuine threat to affordable medicine?
In-depth coverage of the latest AI Regulation developments, trends, and analysis — curated daily.
The debate over drug patents is heating up, with critics accusing Big Pharma of gaming the system. But is this just noise, or a genuine threat to affordable medicine?
The traditional partnership model in Big Law is cracking. We're seeing a rise in nonequity partner tiers, and it's more than just a salary adjustment – it's a structural evolution.
The U.S. Patent and Trademark Office is waging war on fake trademarks, targeting a staggering 10,500 applications and registrations for everything from forged signatures to phantom fees. This isn't just housekeeping; it's a fundamental platform shift in how IP integrity is enforced.
Big Law firm DLA Piper is facing a discrimination lawsuit after terminating a Palestinian lawyer. The alleged grounds for dismissal? A non-existent criminal matter.
The flurry of legal AI acquisitions might be a high-tech bandage on a deeper structural issue. We're not just talking about features, but the very foundation of how these platforms operate.
xAI has been quietly beefing up its power infrastructure in Mississippi, adding a slew of gas turbines even as it's embroiled in a lawsuit alleging violations of the Clean Air Act. It's a move that directly impacts the air people breathe.
Sam Altman is now on the stand. The courtroom drama between Musk and OpenAI is reaching its peak.
A partisan redistricting battle has landed at the Supreme Court, with Virginia Democrats pushing to reinstate a congressional map that would swing four House seats their way. The move follows a state Supreme Court decision that tossed out a voter-approved constitutional amendment allowing the legislature to draw new maps.
The Fifth Circuit's latest move on abortion pills isn't just a legal footnote; it's a flashing red signal of the ongoing judicial battles reshaping fundamental rights. This isn't about the pills themselves; it's about how far courts are willing to bend established legal principles.
The Department of Housing and Urban Development’s move to inject more AI into its systems, alongside a significant expansion of data collection, has triggered a sharp rebuke from digital privacy watchdogs. CDT and EPIC are raising alarms over the implications for citizen privacy.
A sweeping coalition of over 340 organizations, led by the National Immigration Law Center and including EPIC, has formally requested Congress vote against a proposed budget resolution. The move signals a strong opposition to increased funding for U.S. Immigration and Customs Enforcement (ICE) and Customs and Border Protection (CBP).
Elon Musk's lawsuit is dragging OpenAI's safety promises through the mud. Former insiders are airing grievances about a mission drift from pure research to a product-obsessed machine.